Stay tuned and follow the latest
developments and news in Molecular Oncology.
The innovative prime DX® technology is compatible with both FFPET and PLASMA, offering a comprehensive approach to personalized cancer treatment. With 1,021 genes, including over 30 related to homologous recombination […]
Read More
NICE diagnostics guidance – evaluation of effectiveness and efficiency The NICE (National Institute for Health and Care Excellence) diagnostics guidance DG58 givesevidence-based recommendations to guide treatment decisions and evaluate the […]
Read More
This year, our team attended the San Antonio Breast Cancer Symposium (SABCS) in Texas, a key event in breast cancer research. It was a great opportunity to connect with healthcare […]
Read More
Source: Iatronet Nikolaos Tsoulos, MBA, PhD, Molecular Biochemist, CEO of GeneKor Medical SA, and Chairman of the Hellenic Society of Diagnostic Laboratories (EDEM), spoke to Iatronet about accredited diagnostic laboratories […]
Read More
Dr. George Nasioulas, Scientific Director of Genekor Medical S.A. and Molecular Biologist, PhD gave an interview on Shape.gr about liquid biopsies and how they change the prognosis of pancreatic cancer. Pancreatic […]
Read More
Genekor’s Pathology Laboratory now offers the Claudin 18.2 (CLDN 18.2) test, used to administer Zolbetuximab in combination with chemotherapy for patients with advanced or metastatic gastric adenocarcinoma and gastroesophageal junction […]
Read More
The FRα test is performed for the administration of mirvetuximab soravtansine and is aimed at patients with platinum-resistant ovarian cancer who are FRα-positive and have received 1-3 lines of therapy. […]
Read More
The application of next-generation sequencing (NGS) technology in the genetic investigation of hereditary cancer is important for clinical surveillance, therapeutic approach, and reducing the risk of developing new malignancies. The […]
Read More
Genekor announces the opening of our new pathology laboratory. Genekor’s experienced and qualified staff is here to provide you with the most reliable and valid results to enhance your efforts […]
Read More